Reply to "Prognostic Impact and Risk Factors of Immune-Related Pneumonitis in Patients With Non-Small-Cell Lung Cancer Who Received Programmed Death-1 Inhibitors"

Affiliations

• ¹ Department of Respiratory Medicine, Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan.
• ² Department of Respiratory Medicine, Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan. Electronic address: sakakoji@med.nagoya-u.ac.jp.
• ³ Department of Respiratory Medicine, Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan; Department of Respiratory Medicine and Allergy, Tosei General Hospital, Seto, Aichi, Japan.
• ⁴ Department of Respiratory Medicine, Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan; Department of Respiratory Medicine, Handa City Hospital, Handa, Aichi, Japan.
• ⁵ Department of Radiology, Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan.
• ⁶ Department of Respiratory Medicine, Handa City Hospital, Handa, Aichi, Japan.
• ⁷ Department of Respiratory Medicine and Allergy, Tosei General Hospital, Seto, Aichi, Japan.